We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Epigenomic Analyses Could Lead to Novel Therapeutic Drug Targets for Many Diseases

News   May 16, 2018 | Original story from the University of California San Diego

 
Epigenomic Analyses Could Lead to Novel Therapeutic Drug Targets for Many Diseases

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Why Do Some People With COVID-19 Develop Severe Disease?

News

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.

READ MORE

Redesigning Existing Antibiotics To Outmanoeuver Resistant Bacteria

News

Researchers at UC San Francisco are tackling antibiotic resistance using a different approach: redesigning existing antibiotic molecules to evade a bacterium’s resistance mechanisms.

READ MORE

Study Advances Technique To Distinguish Brain Energy Molecules

News

Researchers recently examined how cells in the brains of people at risk for developing Alzheimer's disease make and use energy. This is the first study to distinguish between different energy molecules in the brain using high-powered imaging.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE